Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
131 Views
Favorite
0
Like
Facebook
Tweet
Federal Forum
(1-285) Evaluation of Prescribing Trends for Newly Approved Naloxone HCl Nasal Spray 8mg (Kloxxado™) to Naloxone HCl Nasal Spray 4mg (Narcan®) to Prevent Opioid Overdose
Sunday, December 4, 2022
3:30 PM – 5:00 PM
Location: Bayside A, Level 1
Category:
Research-in-Progress
Topic:
Psychiatry/Neurology
Co-Author(s):
Madeline Salsman, Monica Barrett, Olivia Howard
Primary Author(s)
Sean Blaeser, PharmD
PGY1 Pharmacy Resident
VA TVHS, Tennessee